|
Modeling bladder cancer pathogenesis and tumor evolution
|
1P01CA221757-01A1
|
$1,765,498
|
|
ABATE-SHEN, CORY
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
Novel platform linking cancer-specific glycosylation with cell signaling outcomes
|
1R21CA229044-01
|
$225,250
|
|
ABBOTT, KAREN
|
UNIV OF ARKANSAS FOR MED SCIS
|
|
University of North Carolina Womens Interagency HIV Study UNC WIHS
|
3U01AI103390-05S1
|
$60,652
|
|
ADIMORA, ADAORA
|
UNIV OF NORTH CAROLINA CHAPEL HILL
|
|
Plumbagin in Combination with Vemurafenib for BRAF-mutant Melanoma
|
5R03CA212798-02
|
$74,250
|
|
AFAQ, FARRUKH
|
UNIVERSITY OF ALABAMA AT BIRMINGHAM
|
|
Genetics of Graft-versus-Host Disease
|
1R01CA231141-01
|
$265,229
|
|
AFSHAR-KHARGHAN, VAHID
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
|
Molecular mechanism of bitter melon juice efficacy against pancreatic cancer.
|
5R01CA195708-05
|
$382,616
|
|
AGARWAL, RAJESH
|
UNIVERSITY OF COLORADO DENVER
|
|
Dr. Keiko Akagi, A Bioinformatics Specialist in Cancer Genomics Research at OSU Comprehensive Cancer Center
|
5R50CA211533-03
|
$122,475
|
|
AKAGI, KEIKO
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
|
Metabolic Syndrome and Epigenetic Markers of Breast Cancer in Nigerian Women
|
5K01TW010271-03
|
$134,531
|
|
AKINYEMIJU, TOMI
|
UNIVERSITY OF KENTUCKY
|
|
Extending Chimeric Antigen (CAR) T cell therapy to thoracic cancers
|
1P01CA217805-01A1
|
$2,105,511
|
|
ALBELDA, STEVEN
|
UNIVERSITY OF PENNSYLVANIA
|
|
Oncohistones: Role of Histone H3 Mutations in the Oncogenesis of Pediatric Cancers
|
5P01CA196539-04
|
$1,855,117
|
|
ALLIS, CHARLES
|
ROCKEFELLER UNIVERSITY
|
|
Functional Contribution of Metabolic Complex to Cancer Cell Metabolism
|
1R03CA219609-01A1
|
$72,194
|
|
AN, SONGON
|
UNIVERSITY OF MARYLAND BALT CO CAMPUS
|
|
Womens Interagency HIV Study (WIHS-V)
|
3U01AI035004-25S1
|
$144,370
|
|
ANASTOS, KATHRYN
|
ALBERT EINSTEIN COLLEGE OF MEDICINE, INC
|
|
Steroid hormone regulation of immune responses
|
1R01CA229400-01
|
$384,018
|
|
ANDERSON, ANA
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Unmasking targetable dependencies in cancer with intrinsic or acquired resistance to anti-cancer therapies
|
5F99CA222728-02
|
$35,610
|
|
ANDERSON, GRACE
|
DUKE UNIVERSITY
|
|
Predictive signatures in breast cancer using multiplexed ion beam imaging
|
5DP5OD019822-05
|
$401,249
|
|
ANGELO, ROBERT
|
STANFORD UNIVERSITY
|
|
Cancer Metabolism Training Program
|
1T32CA221709-01A1
|
$201,444
|
|
ANN, DAVID
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
COMPRENDO: Adaptation and Implementation of a Peer-Navigation Intervention to Improve Research Literacy and Diversity in Pediatric Leukemia Clinical Trials
|
1K08CA230306-01
|
$254,821
|
|
ARISTIZABAL, PAULA
|
UNIVERSITY OF CALIFORNIA, SAN DIEGO
|
|
Role of GPR120 and Macrophages in Dietary Omega-3 Fatty Acid Inhibition of Prostate Cancer
|
1R01CA231219-01
|
$444,969
|
|
ARONSON, WILLIAM
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
|
Dual Targeting Redox?active Gold(I) Therapeutics
|
1R15CA232765-01
|
$462,195
|
|
ARUMUGAM, KUPPUSWAMY
|
WRIGHT STATE UNIVERSITY
|
|
DNA repair alterations in metastatic prostate cancer: functional and therapeutic implications
|
1R01CA230516-01
|
$564,655
|
|
ASHWORTH, ALAN
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
Cancer Center Support Grant
|
2P30CA082103-19
|
$7,954,381
|
|
ASHWORTH, ALAN
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
Targeting Nodal/TGF-Beta pathway to inhibit invasion and growth of retinoblastoma
|
1R21CA229919-01
|
$213,694
|
|
ASNAGHI, LAURA
|
JOHNS HOPKINS UNIVERSITY
|
|
Genetic and Dietary Interactions in MMR Deficient Colon Tumorigenesis
|
1R01CA222358-01A1
|
$635,306
|
|
AUGENLICHT, LEONARD
|
ALBERT EINSTEIN COLLEGE OF MEDICINE, INC
|
|
Nutritionally Driven Sporadic Intestinal Tumors: Impact on Stem Cells
|
1R01CA229216-01
|
$493,238
|
|
AUGENLICHT, LEONARD
|
ALBERT EINSTEIN COLLEGE OF MEDICINE, INC
|
|
Integrative framework for identifying dysregulated mechanisms in the tumor-immune microenvironment
|
1K99CA230195-01
|
$134,632
|
|
AZIZI, ELHAM
|
SLOAN-KETTERING INST CAN RESEARCH
|
|
Identifying predictors of racial disparity in treatment and mortality among patients diagnosed with breast cancer in South Carolina and geospatial investigation of breast cancer patient navigation
|
5F99CA222722-02
|
$39,707
|
|
BABATUNDE, OLUWOLE
|
UNIVERSITY OF SOUTH CAROLINA AT COLUMBIA
|
|
Novel ODC Inhibitor Phaseolotoxin in Neuroblastoma
|
1R21CA216867-01A1
|
$193,750
|
|
BACHMANN, ANDRE
|
MICHIGAN STATE UNIVERSITY
|
|
The Duke Preclinical Research Resources for Quantitative Imaging Biomarkers
|
5U24CA220245-02
|
$631,958
|
|
BADEA, CRISTIAN
|
DUKE UNIVERSITY
|
|
Improving Informal Caregivers and Cancer Survivors Psychological Distress, Symptom Management and Health Care Use
|
1R01CA224282-01A1
|
$650,204
|
|
BADGER, TERRY
|
UNIVERSITY OF ARIZONA
|
|
Inter-relationship between microbiota diversity, obesity and race in endometrial cancer
|
5R21CA220269-02
|
$169,106
|
|
BAE-JUMP, VICTORIA
|
UNIV OF NORTH CAROLINA CHAPEL HILL
|
|
SPORE in Bladder Cancer
|
1P50CA221745-01A1
|
$2,299,837
|
|
BAJORIN, DEAN
|
SLOAN-KETTERING INST CAN RESEARCH
|
|
Implementation and Impact of Cancer Screening Navigation by Community Health Workers in Two National Screening Programs
|
1K01CA229996-01
|
$154,723
|
|
BARRINGTON, WENDY
|
UNIVERSITY OF WASHINGTON
|
|
Epigenomic and transcriptomic markers of aggressive prostate cancer among African American men
|
1K07CA230182-01
|
$138,094
|
|
BARRY, KATHRYN
|
UNIVERSITY OF MARYLAND BALTIMORE
|
|
Bioinformatic Analysis of Next Generation Sequencing Data from Cancer Cells
|
5R50CA221848-02
|
$173,980
|
|
BARTOM, ELIZABETH
|
NORTHWESTERN UNIVERSITY AT CHICAGO
|
|
Molecular and Imaging Assessment of Fallopian Tube Health
|
1R21CA229707-01
|
$188,966
|
|
BARTON, JENNIFER
|
UNIVERSITY OF ARIZONA
|
|
U.T. M. D. Anderson Cancer Center SPORE in Ovarian Cancer
|
5P50CA217685-02
|
$1,813,624
|
|
BAST, ROBERT
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
|
Molecular and immunologic evolution of melanomas from pre-neoplastic lesions
|
5R35CA220481-02
|
$951,000
|
|
BASTIAN, BORIS
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
Selective inhibition of Notch1 and ERBB3 by novel neutralizing antibodies to treat melanoma
|
5R21CA218504-02
|
$156,436
|
|
BEDOGNI, BARBARA
|
UNIVERSITY OF MIAMI SCHOOL OF MEDICINE
|
|
DNA Repair Capacity Assays for Lung Disease Risk Assessment
|
1U01CA232505-01
|
$684,671
|
|
BELINSKY, STEVEN
|
LOVELACE BIOMEDICAL & ENVIRONMENTAL RES
|
|
Family-building After Cancer: Preferences, Decisions, and Planning for Young Female Survivors
|
1K07CA229186-01
|
$139,879
|
|
BENEDICT, CATHERINE
|
FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH
|
|
Summer Program to Advance Research Careers (SPARC)
|
5R25CA214256-02
|
$267,323
|
|
BENZ, EDWARD
|
DANA-FARBER CANCER INST
|
|
Brain Tumor SPORE Grant
|
2P50CA097257-16
|
$2,498,496
|
|
BERGER, MITCHEL
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
Case CCC Youth Engaged in Science
|
5R25CA221718-02
|
$486,000
|
|
BERGER, NATHAN
|
CASE WESTERN RESERVE UNIVERSITY
|
|
PSMA - Targeted Small-Molecule Drug Conjugates
|
1R21CA223121-01A1
|
$199,665
|
|
BERKMAN, CLIFFORD
|
WASHINGTON STATE UNIVERSITY
|
|
Development of a surrogate liquid biopsy from the aqueous humor in retinoblastoma eyes.
|
1K08CA232344-01
|
$228,758
|
|
BERRY, JESSE
|
CHILDREN'S HOSPITAL OF LOS ANGELES
|
|
Interrogating malignant gliomas using released tumor DNA in cerebrospinal fluid
|
1R37CA230400-01
|
$374,578
|
|
BETTEGOWDA, CHETAN
|
JOHNS HOPKINS UNIVERSITY
|
|
New paradigms for Hsp90 inhibition
|
5R01CA213566-02
|
$354,105
|
|
BLAGG, BRIAN
|
UNIVERSITY OF NOTRE DAME
|
|
Development of a comprehensive research program in mantle cell lymphoma in the ibrutinib era
|
5K24CA201524-04
|
$176,011
|
|
BLUM, KRISTIE
|
EMORY UNIVERSITY
|
|
Individualizing colorectal cancer patient care using the host and tumor telomere phenotype
|
5R01CA204013-03
|
$657,970
|
|
BOARDMAN, LISA
|
MAYO CLINIC ROCHESTER
|
|
Validation and Advanced Development of Albumin Oxidizability as a Marker of Plasma/Serum Integrity
|
1R33CA217702-01A1
|
$364,966
|
|
BORGES, CHAD
|
ARIZONA STATE UNIVERSITY-TEMPE CAMPUS
|
Total relevant funding to Parathyroid for this search: $186,823
|